Trial intelligence / Profile preview

Buccal mandibular infiltration anesthesia with 4% articaine

RBR-248jysCompleted

Sponsor
Universidade Estadual de Maringá
Start
Sep 2018
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Open-label trial of articaine, mepivacaine and epinephrine in irreversible pulpitis (2 arms), sponsored by Universidade Estadual de Maringá. Started Sep 2018; status: completed.

02

Drugs

articainemepivacaineepinephrine
03

Conditions

irreversible pulpitis

Beyond the preview

Go deeper on RBR-248jys.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-248jys.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call